ES546886A0 - Un procedimiento para preparar un derivado de 1,3-benzotia- zol-2(3h)-ona o 1,3-benzoxazol-2(3h)-ona - Google Patents

Un procedimiento para preparar un derivado de 1,3-benzotia- zol-2(3h)-ona o 1,3-benzoxazol-2(3h)-ona

Info

Publication number
ES546886A0
ES546886A0 ES546886A ES546886A ES546886A0 ES 546886 A0 ES546886 A0 ES 546886A0 ES 546886 A ES546886 A ES 546886A ES 546886 A ES546886 A ES 546886A ES 546886 A0 ES546886 A0 ES 546886A0
Authority
ES
Spain
Prior art keywords
ona
benzotia
zol
benzoxazol
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES546886A
Other languages
English (en)
Other versions
ES8700663A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of ES8700663A1 publication Critical patent/ES8700663A1/es
Publication of ES546886A0 publication Critical patent/ES546886A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ES546886A 1984-09-12 1985-09-11 Un procedimiento para preparar un derivado de 1,3-benzotia- zol-2(3h)-ona o 1,3-benzoxazol-2(3h)-ona Expired ES8700663A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/649,466 US4554284A (en) 1984-09-12 1984-09-12 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones

Publications (2)

Publication Number Publication Date
ES8700663A1 ES8700663A1 (es) 1986-10-16
ES546886A0 true ES546886A0 (es) 1986-10-16

Family

ID=24604912

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546886A Expired ES8700663A1 (es) 1984-09-12 1985-09-11 Un procedimiento para preparar un derivado de 1,3-benzotia- zol-2(3h)-ona o 1,3-benzoxazol-2(3h)-ona

Country Status (10)

Country Link
US (1) US4554284A (es)
EP (1) EP0174811A3 (es)
JP (1) JPS6168476A (es)
AU (1) AU581020B2 (es)
CA (1) CA1248115A (es)
DK (1) DK413585A (es)
ES (1) ES8700663A1 (es)
GR (1) GR852175B (es)
PT (1) PT81110B (es)
ZA (1) ZA856944B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1183453B (it) * 1985-03-01 1987-10-22 Minnesota Mining & Mfg Copulanti 2-equivalenti formatori di colorante cian 5-idrossi-6-acilammino-benzossazol-2-one, elementi fotografici agli alogenuri d'argento e procedimentiche li impiegano
US4720297A (en) * 1985-09-27 1988-01-19 Sumitomo Chemical Company, Limited Benzothiazolones, and their production and use as herbicides
JPS62277347A (ja) * 1986-02-25 1987-12-02 Microbial Chem Res Found 新規生理活性物質ア−ブスタチン類縁化合物
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
US5268381A (en) * 1990-09-26 1993-12-07 Adir Et Compagnie Aminoalkyl-benzothiazolinone and -benzoxazolinone compounds having a high 5-HT1A affinity
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5234924A (en) * 1990-09-26 1993-08-10 Adir Et Compagnie Benzothiazine and benzothiazole compounds useful as analgesics
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds
FR2674524B1 (fr) * 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2717810B1 (fr) * 1994-03-22 1996-04-26 Adir Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
TW356468B (en) * 1995-09-15 1999-04-21 Astra Pharma Prod Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
GB9526511D0 (en) * 1995-12-23 1996-02-28 Astra Pharma Prod Pharmaceutically active compounds
US6749598B1 (en) 1999-01-11 2004-06-15 Flowmedica, Inc. Apparatus and methods for treating congestive heart disease
US7122019B1 (en) 2000-11-28 2006-10-17 Flowmedica Inc. Intra-aortic renal drug delivery catheter
US7780628B1 (en) 1999-01-11 2010-08-24 Angiodynamics, Inc. Apparatus and methods for treating congestive heart disease
US7481803B2 (en) 2000-11-28 2009-01-27 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
US7329236B2 (en) 1999-01-11 2008-02-12 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
WO2004030718A2 (en) 2002-09-20 2004-04-15 Flowmedica, Inc. Method and apparatus for intra aortic substance delivery to a branch vessel
US7993325B2 (en) 2002-09-20 2011-08-09 Angio Dynamics, Inc. Renal infusion systems and methods
US20050197624A1 (en) 2004-03-04 2005-09-08 Flowmedica, Inc. Sheath for use in peripheral interventions
WO2004034767A2 (en) 2002-09-20 2004-04-29 Flowmedica, Inc. Catheter system for renal therapy
US7063679B2 (en) 2002-09-20 2006-06-20 Flowmedica, Inc. Intra-aortic renal delivery catheter
AU2003276903A1 (en) 2002-09-20 2004-05-04 Flowmedica, Inc. Method and apparatus for selective material delivery via an intra-renal catheter
JP2006526464A (ja) 2003-06-05 2006-11-24 フローメディカ，インコーポレイテッド 分枝した身体管腔において両側介入または診断を行うためのシステムおよび方法
WO2005112980A2 (en) 2004-05-14 2005-12-01 Flowmedica, Inc. Bi-lateral local renal delivery for treating congestive heart failure and for bnp therapy
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
US7771401B2 (en) 2006-06-08 2010-08-10 Angiodynamics, Inc. Selective renal cannulation and infusion systems and methods
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
RU2455295C2 (ru) * 2006-12-20 2012-07-10 АстраЗенека AБ 4-ГИДРОКСИ-2-ОКСО-2,3-ДИГИДРО-1,3-БЕНЗОТИАЗОЛ-7-ИЛЬНЫЕ СОЕДИНЕНИЯ ДЛЯ МОДУЛЯЦИИ β2-АДРЕНОРЕЦЕПТОРНОЙ АКТИВНОСТИ
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
UY31905A (es) 2008-06-18 2010-01-29 Astrazeneca Ab Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2927352A1 (de) * 1979-07-06 1981-02-05 Thomae Gmbh Dr K In 6-stellung substituierte benzothiazol-2(3h)-one enthaltende arzneimittel
US4474965A (en) * 1980-01-25 1984-10-02 Monsanto Company 3-Substituted aminoalkyl-2-benzothiazolinones
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
FR2491471A1 (fr) * 1980-10-03 1982-04-09 Cerm Cent Europ Rech Mauvernay Benzoxazolinones substituees, leur preparation et leur application en therapeutique
DE3134590A1 (de) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
FR2536749A1 (fr) * 1982-11-25 1984-06-01 Cerm Cent Europ Rech Mauvernay (amino-2 ethyl)-6 benzoxazolinones substituees, leur preparation et leurs applications en therapeutique
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones

Also Published As

Publication number Publication date
ES8700663A1 (es) 1986-10-16
EP0174811A3 (en) 1987-09-02
ZA856944B (en) 1986-06-25
PT81110B (en) 1987-07-06
JPS6168476A (ja) 1986-04-08
EP0174811A2 (en) 1986-03-19
DK413585A (da) 1986-03-13
AU4714385A (en) 1986-03-20
CA1248115A (en) 1989-01-03
DK413585D0 (da) 1985-09-11
PT81110A (en) 1985-10-01
GR852175B (es) 1986-01-10
US4554284A (en) 1985-11-19
AU581020B2 (en) 1989-02-09

Similar Documents

Publication Publication Date Title
ES546886A0 (es) Un procedimiento para preparar un derivado de 1,3-benzotia- zol-2(3h)-ona o 1,3-benzoxazol-2(3h)-ona
ES545771A0 (es) Un procedimiento para preparar derivados de quiniona.
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES541200A0 (es) Un procedimiento para la preparacion de un derivado de dibenzoilmetano.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES548073A0 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES512852A0 (es) "un procedimiento para preparar nuevos derivados de la n-dihidrotiazolil-3-quinolein-carboxamida".
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES545139A0 (es) Un procedimiento para preparar un derivado de 1,6-naftiri- din-2(1h)-ona
ES543517A0 (es) Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona.
AR230283A1 (es) Un procedimiento para la preparacion de un derivado de 4a,9b-trans-hexahidro-ih-piridoindol enantiomerico(+)o racemico(=)
ES510908A0 (es) "un procedimiento para la preparacion de derivados de piridinona".
ES555459A0 (es) Procedimiento para preparar derivados de saframicina a.
ES548209A0 (es) Un procedimiento para preparar nuevos derivados de 1,3-dihi-dro-6-1-ciano-1-isopropil-n-fenetil-n-metil-omega-aminoal- quil-7--hidroxi-furo-(3,4-c)-piridina
ES532808A0 (es) Un procedimiento para preparar derivados de 7-oxo-4-tia-1-azabiciclo (3.2.0) hep-2-eno
ES548244A0 (es) Un procedimiento para la preparacion de derivados de 5-cetomilbemicina.
ES546802A0 (es) Procedimiento para preparar derivados de 7-oxo-4-tia-1-aza- biciclo(3,2,0)hept-2-eno
ES512520A0 (es) "un procedimiento para preparar derivados heterociclicos de amidoximas".
ES513398A0 (es) "un procedimiento para preparar derivados de dialcohilpirazol".
ES557636A0 (es) Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-benzoxapina
ES547438A0 (es) Un procedimiento para la preparacion de derivados de carbaprem.
ES545820A0 (es) Un procedimiento para la preparacion de nuevos derivados de ftalimida.
ES547054A0 (es) Un procedimiento para la preparacion de un compuesto de 1,3 -diacil-2-oxindol
ES539509A0 (es) Un procedimiento para la preparacion de nuevos derivados de tiacetona.